Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Sitryx Therapeutics Strengthens Leadership Team With Appointment of Ravi M. Rao as Chief Medical Officer
Sitryx Therapeutics Ltd (the “Company”), a biopharmaceutical company pioneering the field of immunometabolism, today announced […]
Pfizer Names David M. Denton Chief Financial Officer
Pfizer Inc. (NYSE: PFE) today announced that David M. Denton will join the Company as […]
CellCentric Strengthens Leadership Team
CellCentric, a clinical stage, private biotechnology company pioneering small molecule inhibition of p300/CBP to treat cancer, […]
Lance Baldo Joins Freenome as Chief Medical Officer
Freenome, a privately held biotech company, announced today that Lance Baldo, M.D. has joined the […]
Healthtech Company Paindrainer AB Recruits New CEO with Experience from Commercialization of Digital Services
Erik Frick is taking over as new CEO of PainDrainer AB with the task of […]
Oxford Science Enterprises Strengthens Investment Teams with Two New Appointments
Oxford Science Enterprises, the Science Business Builder and preferred investment partner of the University of […]
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined […]
Ian Fraser Appointed as EVP Clinical Development
Bionical Emas, a global Contract Research Organisation (CRO) providing services to the pharmaceutical and biotech […]
DECISIO Reveals New Leadership and Closes Series B Funding Round
DECISIO has appointed Major General Elder Granger, M.D. (retired) to the company’s Board of Directors. Dr. Granger is currently […]
Immunovia Appoints Jeff Borcherding, Previously Chief Marketing Officer at Myriad Genetics, to Lead Immunovia's US Business
Immunovia (Nasdaq Stockholm: IMMNOV) has appointed Jeff Borcherding as CEO of its US subsidiary Immunovia, Inc. He […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more